GNHAF   $181.25  6.15% Market Closed

Vifor Pharma AG
Total Cash 993.60M
totalCashPerShare 15.312
EBITDA 549.50M
Total Debt 587.50M
quickRatio 1.464
currentRatio 1.914
Total Revenue 1.81B
debtToEquity 14.802
Revenue/Share 27.94
ROA 0.045760002
ROE 0.06646
grossProfits 1.14B
freeCashflow 302.11M
operatingCashflow 527.40M
earningsGrowth
revenueGrowth
grossMargins 0.62926996
ebitdaMargins 0.30324
operatingMargins 0.20832
profitMargins 0.07969
enterpriseValue 11.83B
forwardPE
floatShares 960.39K
sharesOutstanding 64.89M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.98%
heldPercentInstitutions 0.02%
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding 0.00
bookValue 53.781
Price To Book help_outline 3.37
earningsQuarterlyGrowth
netIncomeToCommon 146.60M
trailingEps 2.24%
forwardEps
enterpriseToEbitda 21.54
lastDividendValue 2.0
lastDividendDate
currentQuarterEstimate
institutionsCount 123
lastUpdated Nov. 2, 2022, 4:08 p.m.